Use access key #2 to skip to page content.
$4.84 0.83 (20.70%)
10/13/2008 4:00 PM

Exelixis, Inc. (EXEL)

CAPS Rating:
*****

A development-stage biotechnology company dedicated to the discovery and development of novel small molecule therapeutics for the treatment of cancer and other serious diseases.

View All Commentary (EXEL)

Recs

4

Avatar stockreader (59.79) Submitted: 2/06/08 5:42 PM : Outperform Start Price: $7.41 EXEL Score: -10.75

Exelixis Inc. is probably the best place to be, when investing in biotechnology. I usually don't put my money in "hot" sectors, but this time I'm willing to make an exception because of the remarkable reputation this company enjoys. Recent price drop of approximately 40% is a good as any place to open a position. But let's not kid ourselves, this one is no sure thing (if there is such a thing).

Report this Post Replies: 0 | Reply

Featured Broker Partners